Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Cridebring

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|March 11, 2023
Can Imaging Using Radiomics and Fat Fraction Analysis Detect Early Tissue Changes on Historical CT Scans in the Regions of the Pancreas Gland That Subsequently Develop Adenocarcinoma?Ronald Lee Korn, Andre Burkett, Jeff Geschwind, et al.
World Journal of Gastrointestinal Oncology|September 18, 2015
Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature reviewErkut Borazanci, Sherri Z Millis, Ron Korn, et al.
British Journal of Cancer|September 2, 2025
Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinomaKuntal Halder, Erkut H Borazanci, Gayle S Jameson, et al.
Frontiers in Oncology|September 27, 2021
Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic AdenocarcinomaSyed Rahmanuddin, Ronald Korn, Derek Cridebring, et al.
Journal of Immunotherapy and Precision Oncology|March 2, 2026
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic CancerMuhammad Rizwan Khawaja, Gayle Jameson, Derek Cridebring, et al.
Genome Medicine|September 29, 2020
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesionsWei Lin, Pawan Noel, Erkut H Borazanci, et al.
The Oncologist|January 23, 2025
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreductionVincent Chung, Angela Alistar, Carlos Becerra, et al.
Cancer Cell|October 6, 2023
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancerNirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, et al.
Investigational New Drugs|September 29, 2018
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastasesHani M Babiker, Sara A Byron, William P D Hendricks, et al.
Cancer|March 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancerGayle S Jameson, Denise J Roe, Erkut Borazanci, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|March 11, 2023
Can Imaging Using Radiomics and Fat Fraction Analysis Detect Early Tissue Changes on Historical CT Scans in the Regions of the Pancreas Gland That Subsequently Develop Adenocarcinoma?Ronald Lee Korn, Andre Burkett, Jeff Geschwind, et al.
World Journal of Gastrointestinal Oncology|September 18, 2015
Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature reviewErkut Borazanci, Sherri Z Millis, Ron Korn, et al.
British Journal of Cancer|September 2, 2025
Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinomaKuntal Halder, Erkut H Borazanci, Gayle S Jameson, et al.
Frontiers in Oncology|September 27, 2021
Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic AdenocarcinomaSyed Rahmanuddin, Ronald Korn, Derek Cridebring, et al.
Journal of Immunotherapy and Precision Oncology|March 2, 2026
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced <i>KRAS</i>-Mutated Metastatic Pancreatic CancerMuhammad Rizwan Khawaja, Gayle Jameson, Derek Cridebring, et al.
Genome Medicine|September 29, 2020
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesionsWei Lin, Pawan Noel, Erkut H Borazanci, et al.
The Oncologist|January 23, 2025
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreductionVincent Chung, Angela Alistar, Carlos Becerra, et al.
Cancer Cell|October 6, 2023
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancerNirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, et al.
Investigational New Drugs|September 29, 2018
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastasesHani M Babiker, Sara A Byron, William P D Hendricks, et al.
Cancer|March 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancerGayle S Jameson, Denise J Roe, Erkut Borazanci, et al.
Pageof 3